» Articles » PMID: 35845994

Irisin is an Effector Molecule in Exercise Rehabilitation Following Myocardial Infarction (Review)

Overview
Journal Front Physiol
Date 2022 Jul 18
PMID 35845994
Authors
Affiliations
Soon will be listed here.
Abstract

Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular disease (CVD). The therapeutic benefits of exercise are mediated partly through improved vascular and increase in metabolic health. Release of exercise-responsive myokines, including irisin, is associated with beneficial effects of exercise in CVD patients. The present review provides an overview of the role of exercise in cardiac rehabilitation of patients with myocardial infarction (MI). Further, the role of irisin as a motion-responsive molecule in improving vascular and metabolic health is explored. Possible mechanism of cardioprotective effect of irisin-mediated exercise on myocardial infarction are also summarized in this review. Irisin is associated with reduced inflammation, antioxidant properties, and anti-apoptotic effect, implying that it is a potential key mediator of the beneficial effects of exercise on vascular and metabolic health. The findings show that irisin is a promising therapeutic target for treatment of patients with cardiovascular disease, particularly post-MI. Further research should be conducted to elucidate the potential mechanisms of cardioprotective effects of irisin and explored whether irisin induced by exercise exerts rehabilitation effects post-MI.

Citing Articles

The role and underlying mechanisms of irisin in exercise-mediated cardiovascular protection.

Guo W, Peng J, Su J, Xia J, Deng W, Li P PeerJ. 2024; 12:e18413.

PMID: 39494293 PMC: 11531754. DOI: 10.7717/peerj.18413.


A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases.

Jin S, Kang P Antioxidants (Basel). 2024; 13(8).

PMID: 39199169 PMC: 11351257. DOI: 10.3390/antiox13080923.


Post-Myocardial Infarction Rehabilitation: The Absence in the Rehabilitation Process of the Diaphragm Muscle.

Bordoni B, Mapelli L, Toccafondi A, Di Salvo F, Cannadoro G, Gonella M Int J Gen Med. 2024; 17:3201-3210.

PMID: 39070222 PMC: 11277820. DOI: 10.2147/IJGM.S470878.


The emerging roles of irisin in vascular calcification.

Wang S, Hu S, Pan Y Front Endocrinol (Lausanne). 2024; 15:1337995.

PMID: 38405155 PMC: 10884194. DOI: 10.3389/fendo.2024.1337995.


The Role of FNDC5/Irisin in Cardiovascular Disease.

Grzeszczuk M, Dziegiel P, Nowinska K Cells. 2024; 13(3.

PMID: 38334669 PMC: 10854770. DOI: 10.3390/cells13030277.


References
1.
Tavassoli H, Heidarianpour A, Hedayati M . The effects of resistance exercise training followed by de-training on irisin and some metabolic parameters in type 2 diabetic rat model. Arch Physiol Biochem. 2019; 128(1):240-247. DOI: 10.1080/13813455.2019.1673432. View

2.
Bi J, Zhang J, Ren Y, Du Z, Li Q, Wang Y . Irisin alleviates liver ischemia-reperfusion injury by inhibiting excessive mitochondrial fission, promoting mitochondrial biogenesis and decreasing oxidative stress. Redox Biol. 2018; 20:296-306. PMC: 6216086. DOI: 10.1016/j.redox.2018.10.019. View

3.
Weber-Rajek M, Radziminska A, Straczynska A, Strojek K, Piekorz Z, Kozakiewicz M . A Randomized-Controlled Trial Pilot Study Examining the Effect of Pelvic Floor Muscle Training on the Irisin Concentration in Overweight or Obese Elderly Women with Stress Urinary Incontinence. Biomed Res Int. 2019; 2019:7356187. PMC: 6720047. DOI: 10.1155/2019/7356187. View

4.
Deng W . Association of Serum Irisin Concentrations with Presence and Severity of Coronary Artery Disease. Med Sci Monit. 2016; 22:4193-4197. PMC: 5100837. DOI: 10.12659/msm.897376. View

5.
Xiong X, Geng Z, Zhou B, Zhang F, Han Y, Zhou Y . FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018; 83:31-41. DOI: 10.1016/j.metabol.2018.01.013. View